GSK’s Rotavirus Vaccine Effective in Trial

GlaxoSmithKline’s rotavirus vaccine Rotarix has been found to be effective against the five most commonly circulating rotavirus types, G1, G2, G3, G4 and G9, according to the new data from a large European clinical vaccine trial published in The Lancet.
TradingMarkets